Leukemia Treatment at Karolinska University Hospital

Leukemia Treatment at Karolinska University Hospital provides specialist hematology care for patients diagnosed with leukemia. Treatment planning is based on the specific type and characteristics of leukemia, disease status, laboratory and pathology findings, overall health, previous treatment, and individual clinical needs.

Price

Price on Request

Why Price on Request?

The cost of leukemia treatment varies depending on the type and stage of leukemia, diagnostic investigations, treatment approach, medications, hospitalization requirements, supportive care, and follow-up needs. A personalized cost estimate can be provided after appropriate medical assessment and review of the patient's records.

Complete Description

What Is Leukemia?

Leukemia is a group of cancers affecting blood-forming tissues, including the bone marrow. Different types of leukemia can develop and progress differently, requiring individualized diagnostic and treatment strategies.

Specialist hematology assessment helps determine the specific leukemia type and guide treatment planning.

Leukemia Diagnosis and Classification

Before treatment begins, the medical team may review blood tests, bone marrow findings, pathology results, immunophenotyping, genetic information, and other diagnostic investigations.

Accurate classification is important because treatment strategies can differ substantially between leukemia types.

Acute Leukemia Treatment

Acute leukemia generally requires timely specialist treatment. Depending on the specific diagnosis, treatment may involve intensive drug-based therapy, targeted medicines, immunotherapy, stem cell transplantation, or other approaches.

The treatment plan is determined according to disease characteristics and the patient's overall medical condition.

Chronic Leukemia Treatment

Some chronic leukemias may progress more slowly and can have different treatment requirements.

Depending on the type and activity of the disease, management may involve targeted medicines, other systemic therapies, active monitoring, or combinations of treatments.

Targeted Treatment

Certain leukemia subtypes may contain molecular or genetic characteristics that allow specific targeted treatments to be considered.

Where appropriate, molecular and genetic testing can help identify treatment options relevant to the patient's disease.

Chemotherapy

Chemotherapy may be used for selected types of leukemia and can be administered according to a carefully planned treatment protocol.

The specific medicines, treatment schedule, duration, and monitoring requirements depend on the leukemia subtype and treatment response.

Immunotherapy

Some patients with leukemia may be considered for immunotherapy or other immune-based treatment approaches.

Suitability depends on the specific leukemia, previous treatment, disease characteristics, and available clinical options.

Stem Cell Transplantation

Stem cell transplantation may be considered for selected patients with certain high-risk, relapsed, or treatment-resistant leukemias.

Eligibility is determined through a detailed assessment of disease status, overall health, previous treatments, donor considerations, and potential benefits and risks.

Relapsed or Refractory Leukemia

Patients whose leukemia returns after treatment or does not respond adequately to initial therapy may require further specialist assessment.

Treatment options may include alternative drug therapies, targeted treatment, immunotherapy, clinical treatment protocols, or stem cell transplantation when appropriate.

Supportive Care

Leukemia treatment can affect blood cell production and may increase the risk of infection, anemia, bleeding, or other complications.

Supportive care may include monitoring blood counts, managing treatment-related symptoms, infection prevention and treatment, transfusion support, and other measures according to individual needs.

Treatment Monitoring

Regular blood tests and other investigations may be used to assess treatment response and monitor for complications.

The treatment plan can be adjusted according to changes in blood counts, disease markers, symptoms, and other clinical findings.

Multidisciplinary Care

Leukemia treatment may involve hematologists, laboratory specialists, transplant specialists, radiologists, pharmacists, nurses, and other healthcare professionals.

A coordinated approach can support diagnosis, treatment delivery, monitoring, and management of complications.

Second Opinion

Patients who have received a leukemia diagnosis or treatment recommendation may seek a specialist second opinion.

Review of pathology reports, laboratory results, imaging, previous treatment records, and other medical information may help clarify the diagnosis and available treatment options.

International Patient Care

International patients may be considered for leukemia assessment and treatment subject to applicable eligibility, referral, appointment, and hospital requirements.

Medical records, pathology reports, laboratory results, imaging studies, treatment history, and medication information may be requested before treatment planning.

Benefits of Leukemia Treatment

• Specialist hematology assessment and treatment planning

• Diagnosis-specific leukemia management

• Evaluation of molecular and genetic disease characteristics

• Access to systemic and targeted treatment approaches when appropriate

• Assessment for immunotherapy or stem cell transplantation

• Monitoring of treatment response

• Supportive care during treatment

• Specialist management of relapsed or refractory disease

Why Choose Karolinska University Hospital?

Karolinska University Hospital provides specialist hematology care within an academic healthcare environment. Patients with leukemia may benefit from multidisciplinary expertise, advanced diagnostic assessment, individualized treatment planning, and coordinated specialist care according to their clinical needs.

Cost & Price on Request

The overall cost depends on the type of leukemia, required diagnostic investigations, treatment approach, medications, hospitalization, supportive care, and follow-up requirements.

Because treatment plans differ significantly between patients, this service is offered at Price on Request following appropriate medical review.

Frequently Asked Questions

What types of leukemia can be treated?

Treatment depends on the specific leukemia diagnosis. Different forms of acute and chronic leukemia require different treatment approaches based on disease characteristics and the patient's clinical condition.

What treatments may be used for leukemia?

Depending on the leukemia type, treatment may include chemotherapy, targeted medicines, immunotherapy, supportive care, or stem cell transplantation when clinically appropriate.

Is stem cell transplantation used for leukemia?

Stem cell transplantation may be considered for selected patients, particularly in certain high-risk, relapsed, or treatment-resistant cases. Eligibility requires detailed specialist assessment.

Can patients seek a second opinion for leukemia treatment?

Yes. A specialist second opinion can include review of diagnostic reports, pathology, previous treatments, disease characteristics, and proposed treatment options.

Can international patients receive leukemia treatment at Karolinska University Hospital?

International patients may be considered subject to applicable eligibility, referral, appointment, and hospital requirements. Medical records and previous treatment information may be required for assessment.

Product Details

Product Name: Leukemia Treatment at Karolinska University Hospital
Hospital: Karolinska University Hospital
Brand: Karolinska University Hospital
Country: Sweden
Location: Stockholm, Sweden
Specialty: Hematology & Blood Disorders
Service Type: Leukemia Treatment
Customer-Facing Price: Price on Request
International Patients: Subject to applicable eligibility and appointment requirements